[ad_1]
Vaccination against the new type of coronavirus (SARS-Cov-2) in Germany may start in early 2021 at the latest, but perhaps in December this year, Federal Government Health Minister Jens Spahn said on Monday, at IDT Biology Vaccine Development and Manufacturing Company in Dessau. during the visit.
The minister is proud that his country is at the forefront of developing vaccines to stop the coronavirus pandemic through BionTech, CureVac and IDT Biology. The government supports all developments, so IDT Biologika received 30 million euros (10.9 billion HUF) in advance of the purchase price of five million doses of vaccines linked to the German population in order to have sufficient resources to finance research and the production. These 30 million euros are “money well spent, an investment in our future”, which seems less and less alarming due to the well-founded hopes that the development of vaccines will be successful.
Clinical trials and licensing of the IDT Biology vaccine are expected to be completed in 2021, the minister said, adding that there is great international interest in the company’s development program. Thanks to the company, which was founded 99 years ago, Dessau is much better known to the world than most Germans realize.
He said vaccines that are already on target could start vaccinating the population in early 2021 at the latest, or even December. Surely there will be vaccines that do not require special refrigeration equipment for transport and storage, so they can even be administered in GP surgeries.
In this case, “we are moving fast,” he said. General practitioners vaccinate approximately 20 million people against the seasonal flu virus in just a few weeks a year.
In an interview with the joint editors of regional newspapers belonging to the German media group Madsack (RedaktionsNetzwerk Deutschland – RND), Jens Spahn said that more than 300 million doses of vaccine had been contracted through EU cooperation and agreements. bilateral, and that vaccination could begin as soon as the first vaccine was received. the marketing authorization of the European Union. Provincial governments and local governments are already working on the creation of so-called vaccination centers. The network of centers could be established in mid-December. The evolution of the vaccination rate will be available on an online platform, broken down by age group and region.
The restrictions due to the epidemic may be gradually removed as the vaccination rate of the most vulnerable groups increases.
SARS-Cov-2 has been detected in 10,864 people in the past 24 hours, according to a Robert Koch National Institute of Public Health (RKI) report on Monday. This is a minimum increase of sixty people from 10,824 a week earlier. Along with the new cases, 929,133 infections were recorded in Germany. The number of deaths associated with the disease caused by the virus (Covid-19) increased by 90 in one day to 14,122.
The number of people who need intensive care for Covid-19 increased by 33 in one day to 3,742, according to the summary of the professional organization of the area of intensive care and accident care (DIVI) on Monday. About 60 percent of them (2,161 people) need mechanical ventilation.
According to the DIVI report, 27,949 intensive care beds are operated nationwide, of which 6,616 are free.
[ad_2]
